Annually, about 790,000 Americans suffer a heart attack, which leaves damaged scar tissue on the heart and limits its ability to beat efficiently. But what if scientists could reprogram scar tissue cells called fibroblasts into healthy heart muscle cells called cardiomyocytes? For the first time, researchers developed a stable, reproducible, minimalistic platform to reprogram human fibroblast cells into cardiomyocytes.